This syndrome demonstrates a cytokine elevation profile that closely resembles that seen in HLH, with IL-6, IFN-γ, and IL-1 playing key roles (Fig. 8).1 CAR-T is a novel therapy for tumor immunotherapy. The gene discussed is IL1A; the disease is hemophagocytic syndrome.